Patents
Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416)
03/2009
03/18/2009EP2035368A1 Process for the preparation of (r)-(-)-3-(carbamoylmethyl)-5-methylhexanoic acid and of pregabalin and synthesis intermediates
03/18/2009EP1040094B1 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
03/18/2009CN101389616A Preparation of optically pure beta-amino acids having affinity for the alpha-2-delta protein
03/18/2009CN101389596A Alignment material for liquid crystal display device of vertical alignment mode and method of preparing the same
03/18/2009CN101389595A Alignment material for liquid crystal display device of vertical alignment mode and method of preparing the same
03/18/2009CN101386600A Process for producing phenylalanine derivative having quinazolinedione skeleton and intermediate for the same
03/18/2009CN100469760C Process for preparing betaine
03/18/2009CN100469749C Process and catalyst for dehydrogenating primary alcohols to make carboxylate
03/17/2009US7504532 Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives, intermediates thereof and methods for their preparation
03/17/2009US7504528 Merocyanine derivatives for cosmetic use
03/17/2009US7504435 Method for stimulating weight loss and/or for lowering triglycerides in patients
03/17/2009CA2406363C A container assembly for fertilization and culture and embryo transfer and method of fertilization and culture employing such a container
03/17/2009CA2342224C Hyperbranched compounds having a tetrafunctional central group, and their use
03/12/2009WO2009030658A1 Radiation curable compositions for food applications
03/12/2009US20090069593 Novel asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid
03/12/2009US20090069579 Process and compound
03/12/2009US20090069421 Crystal polymorph of hydroxynorephedrin derivative hydrochloride
03/12/2009US20090068113 Amphiphilic squaraine dyes, process for preparation thereof and use thereof
03/11/2009EP2033949A1 Radiation curable compositions for food applications
03/11/2009EP2032526A1 Unsaturated alkyl esters of 5-aminolevulinic acid, their preparation and their use
03/11/2009CN101384545A Deuterated catecholamine derivatives and medicaments comprising said compounds
03/11/2009CN101381339A Prodrugs of gaba analogs, compositions and uses thereof
03/11/2009CN101381324A Crystallization disassemble method of chiral alcohol based on schiff base coordination polymer
03/11/2009CN101381323A Method for preparing p-aminobenzoic acid from p-nitrobenzoic acid
03/11/2009CN101381322A Synthetic method of (S/R)-2-amino-3-cyclopentanepropanoic acid
03/11/2009CN101381321A Synthetic method of chiral aminoacid
03/11/2009CN101381317A Third-order nonlinear optical material tetrabutyl ammonium fullerene and synthetic method thereof
03/11/2009CN100467442C Method of preparing potassium phenylaminoacetate in industrial scale from acrylonitrile apparatus by-product formonitrile
03/10/2009US7501538 Erythropoietin receptor activators; inducing red blood cell production and maturation
03/10/2009US7501437 2-[(2-Isopropylsulfanyl-3-oxo-spiro[3.5]non-1-en-1-yl)amino]-3-[4-([2,7]naphthyridin-1-ylamino)phenyl]propanoic acid; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders
03/10/2009CA2358436C Polyunsaturated fatty acid derivatives and their use
03/05/2009WO2009028707A1 Inhibitor of ischemic disorders
03/05/2009US20090062530 Substituted arylalkanoic acid derivatives and use thereof
03/05/2009US20090062355 Pharmaceutical Product
03/05/2009US20090062340 Novel biaromatic compounds which activate ppary type receptors and cosmetic/pharmaceutical compositions comprised thereof
03/05/2009US20090062269 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
03/05/2009US20090060930 Enhanced immunogenicity of tumor associated antigens by addition of alphaGal epitopes
03/05/2009CA2697900A1 Inhibitor of ischemic disorders
03/04/2009EP1472209B1 Lipoxin a4 analogs
03/04/2009CN101376638A Method for separating and purifying glutamine and aminoglutaric acid from glutamine fermentation liquor
03/04/2009CN101376636A Carbpenem penicillin ertapenem intermediate, and preparation and use thereof
03/04/2009CN100465156C A preparation method of glutamic acid compounds and intermediates thereof and novel intermediates used by the method
03/04/2009CN100465155C Ion liquid of amino acid ester cation and a preparation method thereof
03/03/2009US7498460 Isophthalic acid derivatives
03/03/2009CA2328348C 2-methylpropionic acid derivatives and medicinal compositions containing the same
02/2009
02/26/2009WO2009024518A1 Alkali metal salt of glutamic acid n,n-diacetic acid, a process to prepare such salt, and the use thereof
02/26/2009WO2009024492A1 Leukotriene b4 inhibitors
02/26/2009WO2009001203A3 An improved process for the preparation of aprepitant
02/26/2009US20090054662 Process for synthesizing a substituted pyrazole
02/26/2009US20090054543 (Meth) Acryloyl Group-Containing Aromatic Isocyanate Compound and Production Process Thereof
02/26/2009US20090054521 Zwitterionic compounds and use thereof
02/26/2009US20090054450 Compositions and methods of use for treating or preventing lipid related disorders
02/26/2009CA2696967A1 Leukotriene b4 inhibitors
02/26/2009CA2696669A1 Alkali metal salt of glutamic acid n,n-diacetic acid, a process to prepare such salt, and the use thereof
02/25/2009EP2028186A2 Hepatitis C inhibitor tri-peptides
02/25/2009CN101374848A Process to prepare metal complex of N,N-bis(2-hydroxyethyl)glycine
02/25/2009CN101372458A Method for synthesizing acylated enamine without catalyst or solvent
02/25/2009CN100463900C Preparation process of 3-amino-4-cetyl chlorobenzoate
02/24/2009US7495126 using tetrafluorobenzilidine-5-aminosalicylic acid derivative as an intermediate; prevention and treatment of acute and chronic neurodegenerative diseases; Oral preparation
02/24/2009US7495123 useful in the asymmetric synthesis of biologically active molecules; enantioselective hydrogenation of an amine-unprotected prochiral beta-amino acrylic acid or derivative thereof in the presence of a rhodium metal precursor complexed with a chiral mono- or bisphosphine ligand
02/24/2009US7495030 (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
02/24/2009US7494961 Polyphenolics as lubricant oil additives
02/24/2009CA2444208C Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
02/19/2009WO2009022722A1 Tricyclic amine compound
02/19/2009WO2009022098A1 Amino acid derivatives
02/19/2009WO2009021942A1 Novel preparation process
02/19/2009WO2009021589A1 Tyrosinase inhibitors
02/19/2009US20090048343 Compounds and Their Salts Specific to the PPAR Receptors and the EGF Receptors and Their Use in the Medical Field
02/19/2009US20090048147 Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules
02/19/2009US20090047687 Indane Acetic Acid Derivatives and Their Use as Pharmaceutical Agents, Intermediates, and Method of Preparation
02/19/2009US20090047654 Polymer affinity matrix, a method for the production and use thereof
02/19/2009US20090047435 Partially fluorinated ureas and amides
02/19/2009US20090047379 Benzamide Compounds Useful as High Potency Sweet Taste Enhancers
02/19/2009DE102007038250A1 Neues Herstellverfahren New manufacturing process
02/19/2009DE102007038097A1 Tyrosinaseinhibitoren Tyrosinase
02/19/2009DE102004014637B4 Nicht-metabolisierbares Aminosäureanalogon Non-metabolizable amino acid analogue
02/19/2009CA2696205A1 Novel preparation process
02/19/2009CA2695984A1 Tricyclic amine compound
02/18/2009EP2024334A2 Substituted esters as cannabinoid-1 receptor modulators
02/18/2009EP2024325A1 2,5-di(methoxyanilino)terephthalic acid polymorphs and quinacridones realized therefrom
02/18/2009EP2024324A1 Process for preparing gabapentin
02/18/2009EP1554235B1 Process for synthesizing l-y-methylene glutamic acid and analogs
02/18/2009EP1274353B1 A container assembly for fertilization and culture
02/18/2009EP1084137B1 Peptide inhibitors of hepatitis c virus ns3 protease
02/18/2009CN101367749A A set of mesidino mesitoyl derivant, preparation and application thereof
02/18/2009CN101367745A Novel preparation process for nano-aminophenol complex compound
02/18/2009CN101367744A Method for extracting glutamic acid
02/18/2009CN101367743A Method for separation purification of isoleucine from isoleucine liquid
02/18/2009CN100462351C Amino acids with affinity for the alpha-2-delta-protein
02/17/2009US7491748 e.g. (1) 3-(2-((naphthalen-1-ylmethyl)carbamoyl)-4-(2-methylphenoxymethyl)phenyl)propanoic acid; prostaglandin (PGE2) receptor ligand; analgesic, anticarcinogenic agent, antiallergen; neurodegenerative diseases
02/17/2009US7491520 by organism cell biosynthesis from 6-aminohex-2-enoic acid or transform 6-amino-2-hydroxy-hexanoic acid to 6-aminohex-2-enoic acid, in presence of an enzyme having alpha , beta -enoate reductase; chemical intermediates for nylon-6 production
02/12/2009WO2008152260A3 Novel rar receptor agonist ligands and use thereof in human medicine and cosmetics
02/12/2009US20090043125 adding ethylenediamine-N,N'-di(o-hydroxyphenylacetic acid) as preservation stabilizer
02/12/2009US20090043094 Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives
02/12/2009US20090042987 Treatment of neuropathic pain
02/12/2009US20090042926 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
02/12/2009US20090042772 Compounds and methods of treating insulin resistance and cardiomyopathy
02/12/2009US20090042262 Preparation of Pregabalin and Related Compounds
02/12/2009US20090041955 Alignment material for liquid crystal display device of vertical alignment mode and method of preparing the same
02/12/2009US20090041681 Anti-inflammatory inhalation pharmaceutical composition
1 ... 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 ... 215